BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21268062)

  • 1. Key roles of histone methyltransferase and demethylase in leukemogenesis.
    Yoshimi A; Kurokawa M
    J Cell Biochem; 2011 Feb; 112(2):415-24. PubMed ID: 21268062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
    Krishnan S; Horowitz S; Trievel RC
    Chembiochem; 2011 Jan; 12(2):254-63. PubMed ID: 21243713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in histone methyltransferases and histone demethylases].
    Wang X; Zhu WG
    Ai Zheng; 2008 Oct; 27(10):1018-25. PubMed ID: 18851779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
    Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
    ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between epigenetics and metabolism-Yin and Yang of histone demethylases and methyltransferases in cancer.
    Filipp FV
    Brief Funct Genomics; 2017 Nov; 16(6):320-325. PubMed ID: 28369194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development.
    Barry ER; Corry GN; Rasmussen TP
    Expert Opin Ther Targets; 2010 Apr; 14(4):405-18. PubMed ID: 20230194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated histone methyltransferase and demethylase complexes in the control of genes by nuclear receptors.
    Yokoyama A; Fujiki R; Ohtake F; Kato S
    Cold Spring Harb Symp Quant Biol; 2011; 76():165-73. PubMed ID: 21890642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylation and steroid receptor function in cancer.
    Stratmann A; Haendler B
    Mol Cell Endocrinol; 2012 Jan; 348(1):12-20. PubMed ID: 21958694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia: therapeutic impact of epigenetic drugs.
    Altucci L; Clarke N; Nebbioso A; Scognamiglio A; Gronemeyer H
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1752-62. PubMed ID: 15964234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promises and challenges of anticancer drugs that target the epigenome.
    Verbrugge I; Johnstone RW; Bots M
    Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
    Cattaneo F; Nucifora G
    J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future therapeutic potential of histone demethylases: A critical analysis.
    Natoli G; Testa G; De Santa F
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effects produced by arecoline correlated to epigenetic regulation in human K-562 cells.
    Lin PC; Chang WH; Chen YH; Lee CC; Lin YH; Chang JG
    J Toxicol Environ Health A; 2011; 74(11):737-45. PubMed ID: 21480048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of stem cell differentiation by histone methyltransferases and demethylases.
    Pasini D; Bracken AP; Agger K; Christensen J; Hansen K; Cloos PA; Helin K
    Cold Spring Harb Symp Quant Biol; 2008; 73():253-63. PubMed ID: 19022750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylases in development and disease.
    Pedersen MT; Helin K
    Trends Cell Biol; 2010 Nov; 20(11):662-71. PubMed ID: 20863703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.
    Spensberger D; Delwel R
    FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone lysine demethylases: emerging roles in development, physiology and disease.
    Shi Y
    Nat Rev Genet; 2007 Nov; 8(11):829-33. PubMed ID: 17909537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of RUNX3 by histone methyltransferases.
    Lee YM
    J Cell Biochem; 2011 Feb; 112(2):394-400. PubMed ID: 21268059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.